EE693 The Cost-Effectiveness of Imlifidase Idefirix® for Desensitization Treatment of Highly Sensitized Adult Kidney Transplant Patients in Ireland
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1074
https://www.valueinhealthjournal.com/article/S1098-3015(25)03631-9/fulltext
Title :
EE693 The Cost-Effectiveness of Imlifidase Idefirix® for Desensitization Treatment of Highly Sensitized Adult Kidney Transplant Patients in Ireland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03631-9&doi=10.1016/j.jval.2025.09.1074
First page :
Section Title :
Open access? :
No
Section Order :
10613